These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 26221931)

  • 1. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
    Devrim B; Kara A; Vural İ; Bozkır A
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
    Liu Y; Liu J; Liang J; Zhang M; Li Z; Wang Z; Dang B; Feng N
    Nanomedicine; 2017 Oct; 13(7):2219-2229. PubMed ID: 28539275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
    Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications.
    Jose C; Amra K; Bhavsar C; Momin M; Omri A
    Crit Rev Ther Drug Carrier Syst; 2018; 35(6):555-588. PubMed ID: 30317969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
    Mandal B; Bhattacharjee H; Mittal N; Sah H; Balabathula P; Thoma LA; Wood GC
    Nanomedicine; 2013 May; 9(4):474-91. PubMed ID: 23261500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
    Liu Y; Li K; Pan J; Liu B; Feng SS
    Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-lipid hybrid systems used as carriers for insulin delivery.
    Grigoras AG
    Nanomedicine; 2017 Nov; 13(8):2425-2437. PubMed ID: 28821465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
    Chen Y; Deng Y; Zhu C; Xiang C
    Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Coated Nanosized Drug Delivery Systems for an Effective Cancer Therapy.
    Esim O; Hascicek C
    Curr Drug Deliv; 2021; 18(2):147-161. PubMed ID: 32394833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.